X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - WASHINGTONTIMES.COM - Business & Economy - 21/Jan 20:59

FDA approves ketamine-derived nasal spray to fight depression

Johnson & Johnson medication Spravato, a ketamine-based nasal spray, was approved Tuesday by the Food and Drug Administration for use as a sole treatment for depression.

Articles similaires

Sorry! Image not available at this time

Spravato (esketamine) Approved in the U.S. as the First and Only Monotherapy for Adults with Treatment-Resistant Depression

drugs.com - 21/Jan 18:01

Titusville, New Jersey, January 21, 2025 – Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA)...

Sorry! Image not available at this time

Spravato (esketamine) Approved in the U.S. as the First and Only Monotherapy for Adults with Treatment-Resistant Depression

drugs.com - 21/Jan 18:01

Titusville, New Jersey, January 21, 2025 – Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA)...

Sorry! Image not available at this time

FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression

drugs.com - 22/Jan 17:01

WEDNESDAY, Jan. 22, 2025 -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major...

Sorry! Image not available at this time

J&J's Depression Drug Spravato Gets FDA Nod for Monotherapy Use

zacks.com - 22/Jan 16:15

The FDA approves Johnson & Johnson's sNDA for Spravato as a monotherapy for adults with treatment-resistant depression.

Sorry! Image not available at this time

FDA Approves Omvoh for Moderately to Severely Active Crohn Disease

drugs.com - 16/Jan 23:01

THURSDAY, Jan. 16, 2025 -- The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely...

Sorry! Image not available at this time

FDA Approves Lilly's Omvoh (mirikizumab-mrkz) for Crohn's Disease, Expanding Its Use to the Second Major Type of Inflammatory Bowel Disease

drugs.com - 15/Jan 22:01

INDIANAPOLIS, Jan. 15, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has...

Sorry! Image not available at this time

FDA Approves Lilly's Omvoh (mirikizumab-mrkz) for Crohn's Disease, Expanding Its Use to the Second Major Type of Inflammatory Bowel Disease

drugs.com - 15/Jan 22:01

INDIANAPOLIS, Jan. 15, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has...

Sorry! Image not available at this time

FDA Approves Lumakras (sotorasib) in Combination with Vectibix (panitumumab) for Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer

drugs.com - 17/Jan 02:01

THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved...

Sorry! Image not available at this time

FDA Approves Marketing of Nicotine Pouches: A Safer Way to Quit?

medindia.net - 21/Jan 12:54

The U.S. Food and Drug Administration (FDA) has approved the bmarketing/b of 20 ZYN bnicotine pouch/b products after a bthorough scientific

Sorry! Image not available at this time

What is Red Dye 3 and why has the US FDA banned it in food and drinks?

aljazeera.com - 16/Jan 11:49

The Food and Drug Administration (FDA) granted a 2022 petition by consumer advocacy groups to ban the use of the dye.

Les derniers communiqués